Who Paid My Doc
Xen Glaucoma Treatment System
Device Eye Care
PDI 10888628032439
General payments
$2,195,032
Research payments
$2,374,772
Through program year 2025, $2,195,032 in general payments and $2,374,772 in research payments were reported against Xen Glaucoma Treatment System (Eye Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $820,881 | 5,929 |
| 2025 | Research | $990,611 | 180 |
| 2024 | General | $692,609 | 3,910 |
| 2024 | Research | $700,354 | 144 |
| 2023 | General | $681,541 | 4,090 |
| 2023 | Research | $683,807 | 157 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
13,929 general · 481 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.